Manifold Bio
About
Manifold Bio is a biotechnology company developing an AI-guided, high-throughput in vivo (HTV) discovery engine. Their platform integrates massively multiplexed in vivo screening with AI-powered protein design to create targeted biologics, optimizing properties like pharmacokinetics and biodistribution directly within living systems. They aim to accelerate the development of tissue-targeted medicines for various diseases.
Key facts
At-a-glance profile data
- Website
- manifold.bio
- Headquarters
- Boston, United States
- Founded
- 2018
- Employees
- 68
- Total funding
- $118M (Series B)
- Business model
- B2B
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 18 Dec 2025 | Series B | $18M | Reach Capital |
| 4 Nov 2025 | Other Equity | $55M | - |
| 1 Jun 2022 | Series A | $40M | Triatomic Capital |
| 1 Sept 2020 | Seed | $5M | Playground Global |
Tech stack
Detected on manifold.bio and in its job posts, last scanned 18 Sept 2026. Run your own scan
- Frontend
- Tailwind CSS, Bootstrap
- Backend
- Python
- Analytics
- Google Tag Manager
- CMS / Builders
- Webflow
- CDN
- Cloudflare
- Hosting
- AWS, Google Cloud
- Email provider
- Google Workspace
- Hiring platform
- Greenhouse
- Video / media
- Vimeo
- DevOps
- Docker, Kubernetes
Add first review
Frequently asked
How much funding has Manifold Bio raised?
Manifold Bio has raised a total of $118M in funding. The most recent round on record is Series B.
How many employees does Manifold Bio have?
Manifold Bio has approximately 68 people on record.